Belgium
· Delayed Price · Currency is EUR Onward Medical Statistics
Total Valuation
Onward Medical has a market cap or net worth of EUR 165.87 million. The enterprise value is 152.98 million.
| Market Cap | 165.87M |
| Enterprise Value | 152.98M |
Important Dates
The next estimated earnings date is Friday, September 27, 2024.
| Earnings Date | Sep 27, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
Onward Medical has 34.63 million shares outstanding. The number of shares has increased by 1.25% in one year.
| Shares Outstanding | 34.63M |
| Shares Change (YoY) | +1.25% |
| Shares Change (QoQ) | +11.11% |
| Owned by Insiders (%) | 8.43% |
| Owned by Institutions (%) | 20.62% |
| Float | 18.17M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 271.77 |
| PB Ratio | 8.06 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -4.23 |
| EV / Sales | 287.55 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -4.68 |
Financial Position
The company has a current ratio of 4.70, with a Debt / Equity ratio of 94.11.
| Current Ratio | 4.70 |
| Quick Ratio | 4.52 |
| Debt / Equity | 94.11 |
| Debt / EBITDA | n/a |
| Debt / FCF | -0.52 |
| Interest Coverage | -25.77 |
Financial Efficiency
Return on equity (ROE) is -102.55% and return on invested capital (ROIC) is -43.54%.
| Return on Equity (ROE) | -102.55% |
| Return on Assets (ROA) | -36.87% |
| Return on Capital (ROIC) | -43.54% |
| Revenue Per Employee | 5,374 |
| Profits Per Employee | -365,465 |
| Employee Count | 99 |
| Asset Turnover | 0.01 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +5.74% in the last 52 weeks. The beta is 0.84, so Onward Medical's price volatility has been lower than the market average.
| Beta (5Y) | 0.84 |
| 52-Week Price Change | +5.74% |
| 50-Day Moving Average | 4.96 |
| 200-Day Moving Average | 4.56 |
| Relative Strength Index (RSI) | 44.76 |
| Average Volume (20 Days) | 17,910 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Onward Medical had revenue of EUR 532,000 and -36.18 million in losses. Loss per share was -1.20.
| Revenue | 532,000 |
| Gross Profit | -14.82M |
| Operating Income | -35.46M |
| Pretax Income | -36.07M |
| Net Income | -36.18M |
| EBITDA | -35.23M |
| EBIT | -35.46M |
| Loss Per Share | -1.20 |
Balance Sheet
The company has 29.77 million in cash and 16.87 million in debt, giving a net cash position of 12.89 million or 0.37 per share.
| Cash & Cash Equivalents | 29.77M |
| Total Debt | 16.87M |
| Net Cash | 12.89M |
| Net Cash Per Share | 0.37 |
| Equity (Book Value) | 17.93M |
| Book Value Per Share | 0.59 |
| Working Capital | 24.74M |
Cash Flow
In the last 12 months, operating cash flow was -32.27 million and capital expenditures -422,000, giving a free cash flow of -32.69 million.
| Operating Cash Flow | -32.27M |
| Capital Expenditures | -422,000 |
| Free Cash Flow | -32.69M |
| FCF Per Share | -0.94 |
Margins
| Gross Margin | n/a |
| Operating Margin | -6,665.98% |
| Pretax Margin | -6,780.83% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | -6,145.11% |
Dividends & Yields
Onward Medical does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -1.25% |
| Shareholder Yield | -1.25% |
| Earnings Yield | -25.05% |
| FCF Yield | -19.71% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |